|
MechanismDNA polymerase inhibitors [+1] |
|
|
Active Indication- |
|
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.US |
First Approval Date20 Sep 2002 |
100 Clinical Results associated with GlaxoSmithKline (Tianjin) Co., Ltd
0 Patents (Medical) associated with GlaxoSmithKline (Tianjin) Co., Ltd
100 Deals associated with GlaxoSmithKline (Tianjin) Co., Ltd
100 Translational Medicine associated with GlaxoSmithKline (Tianjin) Co., Ltd